Betahistine dihydrochloride 8 mg Tablets

Licence status
Authorised: 21/01/2022
Active substances
Betahistine dihydrochloride
Dosage Form
Tablet
Licence number
PA22871/017/001
Licence holder
Azure Pharmaceuticals Ltd.

Product documents

Licence information

ATC code
N07CA01 betahistine
Legal supply status
Product subject to prescription which may be renewed (B)
Place of sale
Supply through pharmacies only
Marketing availability
Marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
21/01/2022

Interchangeable information